SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
MESSINA RICHARD

(Last) (First) (Middle)
C/O JUNIPER PHARMACEUTICALS INC.
33 ARCH STREET SUITE 3110

(Street)
BOSTON MA 02110

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2018
3. Issuer Name and Ticker or Trading Symbol
JUNIPER PHARMACEUTICALS INC [ JNP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 8,032 D
Common Stock 250 I See Footnote(1)
Common Stock 250 I See Footnote(2)
Common Stock 250 I See Footnote(3)
Common Stock 8,000 I See Footnote(4)
Common Stock 9,700 I See Footnote(5)
Common Stock 41,000 I See Footnote(6)
Common Stock 14,500 I See Footnote(7)
Common Stock 2,001 I See Footnote(8)
Common Stock 28,000 I See Footnote(9)
Common Stock 6,250 I See Footnote(10)
Common Stock 875 I See Footnote(11)
Common Stock 100,000 I See Footnote(12)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. shares held by Richard Messina CF Jacqueline Messina UTMA
2. shares held by Richard Messina CF Carolyn Messina UTMA
3. shares held by Richard Messina CF Madeline Messina UTMA
4. Shares held by Equity TR Co TTEE FBO Pamela Brocious SEP
5. Shares held by Steve A. Sanders and Partners
6. Shares held by Citistaffing LLC Profit Sharing
7. Shares held by Summit Capital Associates.
8. Shares held by Benchmark Pellinore Group
9. Shares held by SCA Retirement Plan DTD 1/1/91
10. Shares held by Pamela Brocious M/P PEN PL
11. Shares held by SCA Money Purchase Plan DTD 1/1/94 Attn Richard Messina
12. Shares held by The Benchmark Company LLC - Investment Purposes
Remarks:
/s/ Jeffrey Young, Attorney-in-Fact 03/22/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Power of Attorney

      Know all by these presents that the undersigned hereby constitutes and
appoints Alicia Secor and Jeffrey Young, and with full power of substitution, as
the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as a director of Juniper Pharmaceuticals, Inc., a Delaware corporation (the
Company), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended, and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such
 attorney-in-fact may approve in such
attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 21st  day of March, 2018.

/s/ Richard Messina
________________________	
Name: RICHARD MESSINA